RICHARD K. PRINS - 22 Nov 2021 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
22 Nov 2021
Net transactions value
-$20,550
Form type
4
Filing time
23 Nov 2021, 19:17:21 UTC
Previous filing
08 Jun 2021
Next filing
13 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Options Exercise $85,550 +5,000 +11% $17.11 50,179 22 Nov 2021 Direct
transaction AMPH Common Stock Sale $106,100 -5,000 -10% $21.22 45,179 22 Nov 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Options Exercise $0 -5,000 -25% $0.000000 15,291 22 Nov 2021 Common Stock 5,000 $17.11 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option are fully vested and immediately exercisable.